Gordon B Mills Selected Research

Proteome

10/2023	The Breast Cancer Proteome and Precision Oncology.
1/2020	Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays.
1/2020	Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
1/2019	TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
1/2019	Breast cancer quantitative proteome and proteogenomic landscape.
10/2018	Personalized Integrated Network Modeling of the Cancer Proteome Atlas.
1/2018	Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
12/2017	Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
11/2017	Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.
7/2014	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gordon B Mills Research Topics

Disease

460	Neoplasms (Cancer) 05/2024 - 02/2002
143	Breast Neoplasms (Breast Cancer) 11/2023 - 04/2003
88	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2002
36	Neoplasm Metastasis (Metastasis) 05/2024 - 10/2002
33	Carcinogenesis 12/2022 - 03/2003
29	Melanoma (Melanoma, Malignant) 03/2023 - 08/2006
25	Carcinoma (Carcinomatosis) 01/2023 - 02/2002
20	Endometrial Neoplasms (Endometrial Cancer) 04/2024 - 07/2011
19	Squamous Cell Carcinoma of Head and Neck 04/2022 - 04/2006
18	Triple Negative Breast Neoplasms 11/2023 - 04/2012
14	Ovarian Epithelial Carcinoma 05/2020 - 07/2003
13	Lung Neoplasms (Lung Cancer) 05/2024 - 06/2003
11	Ascites 11/2020 - 02/2002
8	Glioma (Gliomas) 01/2023 - 04/2002
8	Residual Neoplasm 05/2022 - 02/2012
8	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 10/2002
8	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021 - 04/2006
7	Hypoxia (Hypoxemia) 01/2019 - 02/2012
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 03/2006
6	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 12/2007
6	Bites and Stings (Sting) 01/2022 - 01/2019
6	Disease Progression 11/2020 - 05/2006
6	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 09/2007
5	Pathologic Complete Response 11/2023 - 07/2013
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2009
5	Leukemia 01/2022 - 04/2006
5	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 03/2002
5	Obesity 12/2017 - 02/2011

Drug/Important Bio-Agent (IBA)

167	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2003
73	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2003
47	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2004
38	Messenger RNA (mRNA)IBA 10/2021 - 04/2003
37	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2003
35	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020 - 04/2003
33	Estrogen ReceptorsIBA 11/2023 - 04/2009
33	Phosphotransferases (Kinase)IBA 01/2022 - 01/2003
24	Hormones (Hormone)IBA 11/2019 - 04/2003
23	Small Interfering RNA (siRNA)IBA 08/2021 - 03/2006
22	lysophosphatidic acidIBA 12/2022 - 05/2002
20	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 08/2010
20	Estrogens (Estrogen)FDA Link 01/2021 - 08/2007
19	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2009
18	PlatinumIBA 11/2023 - 05/2008
18	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 06/2003
16	Immune Checkpoint InhibitorsIBA 12/2023 - 11/2017
16	Phenobarbital (Luminal)FDA Link 01/2023 - 05/2009
16	EnzymesIBA 01/2022 - 03/2003
15	ErbB Receptors (EGF Receptor)IBA 10/2021 - 05/2003
15	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020 - 02/2002
13	ProteomeIBA 10/2023 - 12/2010
12	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 04/2002
12	Lysophosphatidic Acid ReceptorsIBA 06/2010 - 01/2002
11	Trastuzumab (Herceptin)FDA Link 10/2023 - 10/2003
11	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 04/2003
11	LipidsIBA 01/2016 - 04/2002
11	TOR Serine-Threonine KinasesIBA 01/2016 - 04/2003
10	Sirolimus (Rapamycin)FDA Link 01/2021 - 02/2004
10	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 04/2003
9	Indicators and Reagents (Reagents)IBA 01/2023 - 04/2003
9	AntibodiesIBA 01/2023 - 03/2004
9	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2021 - 05/2009
9	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2003
9	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 03/2010
9	CytokinesIBA 01/2018 - 03/2004
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2003
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 02/2002
8	PhosphoproteinsIBA 01/2017 - 01/2009
7	Drug CombinationsIBA 12/2022 - 03/2009
7	MK 2206IBA 04/2022 - 10/2012
7	Tamoxifen FDA LinkGeneric 01/2021 - 08/2008
7	IntegrinsIBA 12/2020 - 10/2007
7	Fulvestrant (Faslodex)FDA Link 01/2020 - 05/2009
7	Tyrosine Kinase InhibitorsIBA 10/2018 - 05/2003
7	src-Family KinasesIBA 10/2018 - 01/2003
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2017 - 01/2003
7	Interleukin-8 (Interleukin 8)IBA 06/2013 - 09/2003
6	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021 - 01/2017
6	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 02/2006
6	Epidermal Growth Factor (EGF)IBA 10/2019 - 08/2005
6	Protein Isoforms (Isoforms)IBA 07/2018 - 06/2003
6	Formaldehyde (Formol)FDA Link 10/2016 - 02/2009
6	ParaffinIBA 10/2016 - 02/2009
6	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2014 - 10/2004
6	Monomeric GTP-Binding ProteinsIBA 02/2012 - 05/2003
6	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 05/2009 - 02/2002
5	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2023 - 04/2009
5	Cetuximab (Erbitux)FDA Link 10/2021 - 12/2004
5	AntigensIBA 01/2021 - 09/2009
5	NucleotidesIBA 12/2019 - 08/2006
5	Long Noncoding RNAIBA 10/2017 - 09/2014
5	CyclinsIBA 01/2017 - 05/2006
5	MTOR InhibitorsIBA 04/2016 - 04/2005
5	Transcription Factors (Transcription Factor)IBA 08/2015 - 03/2004
5	TensinsIBA 09/2014 - 03/2006

Therapy/Procedure

209	Therapeutics 05/2024 - 01/2002
43	Drug Therapy (Chemotherapy) 01/2022 - 02/2002
23	Immunotherapy 03/2023 - 10/2016
12	Neoadjuvant Therapy 12/2023 - 04/2011
10	Precision Medicine 01/2022 - 05/2013